Federal Drug Administration (FDA)

Photo
22.11.2022 • News

US Anti-abortion Groups Seek Ban on Mifepristone

As abortion continues to dominate the political discussion in the US and at least half of the 50 states move toward outlawing the procedure in response to last summer’s Supreme Court decision that it is not a constitutional right, conservative and religious groupings are pushing for a ban on sales of the oral abortifacient Mifeprex. (mifepristone).

Photo
15.07.2022 • News

FDA Finally Greenlights Novavax Covid Vaccine

It took longer than expected, but the US Food and Drug Administration (FDA) on July 13 finally granted an Emergency Authorization (EUA) to Nuaxovid, the protein-based sCovid-19 shot developed by Novavax.

Photo
12.07.2022 • News

HRA Pharma Seeks FDA Approval for OTC Contraceptive

In the wake of the US Supreme Court’s recent overturn of Roe v. Wade, a 50-year-old decision by an earlier team of justices that guarantees women the right terminate a pregnancy, attention has turned to the so-called morning-after pill mifepristone – which remains legal for now – and easier access to birth control.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.